In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...

Semaglutide, a GLP-1 receptor analogue, was originally intended to treat diabetes (brand name Ozempic) but has found a new use resulting in rocketing popularity (Wegovy). Upon discovering that those ...

Concerns around those who are a healthy weight obtaining injections privately, as well as distribution of fake pens ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not ...

Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial investigating ...